Now I have all the information I need to write the consolidated review. Let me compile my findings.

---

## Summary

InnoGym proposes a benchmark and framework for evaluating the innovation potential of AI agents, moving beyond correctness-only evaluation by introducing two complementary metrics: **performance gain (G)** — improvement over best-known solutions — and **novelty (N)** — methodological dissimilarity from prior solutions. The benchmark comprises 18 carefully curated *Improvable Tasks* drawn from real-world competitions (NeurIPS, KDD Cup, ROADEF, etc.), standardized through a rigorous two-stage filtering pipeline (197→72→18). The paper also provides **iGym**, a unified execution environment. Experiments with three agent frameworks (MLAB, CodeAct, AIDE) on DeepSeek-v3.1 reveal that while some agents achieve moderate novelty scores, they fail to translate this into positive performance gains, highlighting a gap between creativity and robustness.

## Strengths

1. **Principled formalization of innovation via two complementary metrics.** The paper formally defines Performance Gain (G) in Equation (2) and Novelty (N) in Equation (3), grounding innovation in measurable quantities that go beyond correctness and capture both *doing better* and *doing differently*. (Section 2.2)

2. **Rigorous two-stage benchmark curation pipeline.** The filtering process from 197 initial competition tasks down to 18 standardized *Improvable Tasks* is well-designed and described: resource-availability filtering, evaluator validation with Pearson ≥ 0.9 and Kendall-τ ≥ 0.8 consistency checks, solution collection, and data partitioning into visible/hidden splits. (Section 3.1, Figure 2)

3. **Empirical finding of a novelty–robustness gap.** Table 2 shows that agents such as MLAB achieve moderate novelty scores (up to 70.83) while producing large negative gains (−14.64 to −54.80). The paper's conclusion that "the primary bottleneck … is not a deficit of novel ideas, but rather the inability to translate them into correct and robust implementations" is supported by the data and is a genuinely useful observation for the field. (Section 4.2, Table 2)

4. **Controlled experiments on Circle Packing revealing innovation dynamics.** The solution-space tree (Figure 5a) and complex-plane representation (Figure 5b) provide an elegant visualization of how performance and novelty evolve during iterative refinement. The temperature analysis (Figure 6c) identifying a "sweet spot" (0.5–0.75) is a concrete, practically useful finding. (Section 4.3)

5. **iGym execution environment.** The paper provides a unified SDK that addresses real limitations in existing agent execution frameworks (OpenHands, AutoGen) by supporting asynchronous tool dispatch, recovery mechanisms, and both workflow-style and autonomous agent paradigms. (Section 3.5)

## Weaknesses

### Fatal
None.

### Major

1. **Novelty metric depends on proprietary, opaque models without demonstrated reliability in the main text.** The distance function D, which is the lynchpin of the entire novelty evaluation, is instantiated via Codex (for strategy extraction) and GPT-5 (for dissimilarity scoring). While the paper states that "a more detailed analysis of the behavior and reliability of D" is provided in Appendix F, the main text contains no human agreement study, sensitivity analysis, or ablation demonstrating that the LLM judge produces stable and accurate novelty scores. For a benchmark that aims to serve as a community standard for measuring innovation, this is a meaningful concern — even if the prompts and validation are in the (stripped) appendix. The novelty scores in Table 2 should ideally be supported by at least a small-scale human calibration study in the main text.

2. **No human novelty baselines.** The paper reports that agents achieve novelty scores of 33–83 on various tasks, but never establishes what a "reasonable" or "expected" novelty score looks like. How novel are human solutions compared to prior work on these same tasks? Without this calibration, it is unclear whether agent novelty scores of 56.55 (MLAB average) are high, moderate, or low. The agent scores float without an anchor — are they impressive or trivial relative to human baselines?

### Minor

3. **10 of 30 agent–task combinations produce "/" (no valid submission), with no failure analysis.** For CDML and PTTALC, all three agents failed. The paper attributes this to "complex data formats or intricate requirements," but does not break down *why* submissions failed — was it a correct script that failed a validator check, a dependency error, a timeout, or an agent that produced no submission at all? A deeper failure analysis would strengthen confidence that the benchmark is measuring agent capability rather than environment brittleness.

4. **No statistical variance reported.** Results are best-of-3 runs with no confidence intervals, standard deviations, or per-run breakdowns. Given the small number of runs and the stochastic nature of LLM-based agents, variance could be substantial. Reporting means and standard deviations (or at minimum the run-level data) would significantly strengthen the reliability of the conclusions.

5. **Resource disparity between agents (12h) and human competitors (weeks–months) is not fully contextualized when drawing conclusions.** The paper states "no agent managed to surpass the state-of-the-art human solutions" and frames negative performance gains as agent limitations. This is factually correct, but the presentation would benefit from more explicitly framing the benchmark as measuring *efficient innovation under limited resources* rather than general innovation capability.

### Trivial
None.

## Nice-to-Haves

- Providing an open-source alternative for the distance function D (e.g., embedding-based cosine similarity with a frozen open-source code encoder, or AST overlap metrics) alongside the LLM-as-judge approach would dramatically improve reproducibility and serve as a practical baseline.
- The iGym architecture description in the main text is very brief (half a page, largely referring to Appendix C). A slightly expanded description of how it handles the limitations it claims to address would help readers assess the environment's fairness without reading the appendix.

## Removed Points

- **"Novelty metric is unverifiable / no evidence of reliability"** — Removed because the paper explicitly states that validation of D is in Appendix F (Section 4.1: "We provide a more detailed analysis of the behavior and reliability of D in Appx. F"). Per the rules, weaknesses about missing appendix content that was stripped by the parser cannot be held against the paper.
- **"GPT-5 is called hypothetical while being used as judge (inconsistency)"** — Removed because the paper only calls GPT-5 "hypothetical" in the *base model comparison* context in Section 4.3 (Fig 6(b)), not in the novelty judge context (Section 4.1) where GPT-5 is treated as a real model cited as (OpenAI, 2025a). The harsh critic conflated two separate uses.
- **"Tasks may not be all public"** — Removed per rules: cited resources are assumed to exist. The paper lists all sources and provides a GitHub link.
- **"Agent-human comparison is fundamentally unfair / leads to misleading conclusions"** — Demoted to Minor. The paper simply reports factual results and does not make claims beyond what the data supports. The comparison is useful information even with the resource gap acknowledged.
- **Various formatting/style nitpicks and speculative weaknesses** — Removed per filtering rules.
- **Strength Finder's generic strengths** — Removed generic or unsupported claims (e.g., "addressed an important problem" without specificity).
- **Strength about "Agent-as-judge with structured rubrics"** — Removed because this strength conflicts with the verified weakness about proprietary judge opacity, and the rubrics are only described in the removed appendix.

## Novel Insights

The reviewers' input surfaces one genuinely novel observation that the paper itself does not fully articulate: **the finding that agents can achieve moderate-to-high novelty (46–67 on average) while simultaneously producing large negative performance gains (−24 to −43 on average) suggests that current LLM-based agents may be operating in a qualitatively different regime from human innovators.** Humans on these competitive tasks tend to produce solutions that are either (a) incremental refinements of existing methods (low N, moderate positive G) or (b) genuine breakthroughs (high N, high positive G). The fact that agents reliably produce high-N + negative-G combinations indicates that their "novelty" may stem from hallucinated or incorrect approaches rather than from genuine methodological divergence within the feasible region. This is worth testing explicitly.

## Suggestions

1. **Validate the novelty distance function D against human judgments** on a representative subset of solutions. A small-scale study (e.g., 20–30 pairwise comparisons rated by 3 domain experts, reporting Cohen's κ or Spearman correlation) would dramatically strengthen confidence in the novelty metric. Even if this is in Appendix F, a summary in the main text would help.

2. **Provide an open-source alternative measure** for D (e.g., embedding cosine similarity from a frozen open-source code encoder like CodeBERT or AST-based structural distance) as a secondary, fully reproducible baseline. This would let researchers who cannot access GPT-5 still compute novelty scores.

3. **Report per-run variance** (mean ± std over 3 runs) in Table 2, or at minimum list the individual run scores in an appendix for transparency.

4. **Include a failure-case breakdown** for the "/" entries: distinguish between "environment/setup failure," "agent timeout," "validator rejection," and "agent produced no output." This would clarify what the benchmark is actually measuring.

5. **Calibrate novelty with at least one human-constructed solution** per task, so readers can interpret whether an agent novelty score of 56 is high or low relative to the range of human methodological variation.

## Score and Decision

### Calibration Anchors

**Round 1 — Bracketing:**

| Path | Avg Score | Round | Comparison |
|------|-----------|-------|------------|
| nE3flbe88p.md (TeamCraft) | 3.25 | R1 | Rejected/withdrawn. Weak contribution and execution. InnoGym is clearly stronger. |
| koza5fePTs.md (Planning Capabilities) | 2.00 | R1 | Rejected. Unclear contribution. InnoGym is far stronger. |
| S2oTVrlcp3.md (SmartPlay) | 6.75 | R1 | Accepted poster. Well-received benchmark with cleaner evaluation. InnoGym has more novelty in its framework but weaker evaluation methodology. Comparable or slightly weaker. |
| fp6t3F669F.md (BALROG) | 6.25 | R1 | Accepted poster. Combined existing environments. InnoGym has more novel contribution. |
| tc90LV0yRL.md (Cybench) | 8.67 | R1 | Accepted oral. Exceptional execution. InnoGym is clearly weaker. |

**Round 2 — Narrowing:**

| Path | Avg Score | Round | Comparison |
|------|-----------|-------|------------|
| 6z4YKr0GK6.md (ScienceAgentBench) | 5.67 | R2 | Accepted poster. Very similar scope — both benchmark agents on real-world tasks. ScienceAgentBench has more tasks (102) with expert validation; InnoGym has more novel metrics (G and N). Roughly comparable quality. |
| vunPXOFmoi.md (WorfBench) | 6.40 | R2 | Accepted poster. Solid benchmark with clear evaluation. InnoGym is comparable in contribution novelty but weaker in metric validation. |
| DeVm3YUnpj.md (Agent-as-a-Judge) | 5.67 | R2 | Rejected. Used proprietary models as judges, rejected primarily for limited technical contribution. InnoGym has more novel contribution but similar judge reliability concerns. |
| IIzehISTBe.md (ST-WebAgentBench) | 4.25 | R2 | Rejected. Significant methodological issues with metric validity. InnoGym is clearly stronger. |
| H0UcwHgwEO.md (LLF-Bench) | 4.75 | R2 | Rejected. Narrow scope with limited evaluation. InnoGym is stronger. |

**Final score determination:** The round-1 bracket placed the paper between 5 and 7. Round 2 narrows this: InnoGym is clearly stronger than rejected benchmarks scoring 4–5 (ST-WebAgentBench, LLF-Bench) and comparable to accepted benchmarks scoring 5.5–6.5 (ScienceAgentBench at 5.67, BALROG at 6.25). It is somewhat weaker than the best mid-range benchmarks (SmartPlay at 6.75). The paper's main vulnerability — reliance on proprietary LLMs for its core novelty metric without demonstrated validation in the main text — is a meaningful but not fatal weakness. The contribution (innovation framework, task curation, empirical findings) is genuinely novel and valuable. I place the paper at **5.5**, comparable to ScienceAgentBench (5.67, accepted poster).

---

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Accept</decision>